A Serendipitous Preoperative Trial of Combined Ipilimumab Plus Nivolumab for Localized Prostate Cancer

Clin Genitourin Cancer. 2022 Apr;20(2):e173-e179. doi: 10.1016/j.clgc.2021.12.004. Epub 2021 Dec 10.
No abstract available

Keywords: Immune checkpoint inhibitors; Neo-adjuvant therapy; Prostate cancer; Surgery.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Humans
  • Ipilimumab / therapeutic use
  • Male
  • Melanoma*
  • Nivolumab / therapeutic use
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms* / surgery

Substances

  • Ipilimumab
  • Nivolumab